Zeyu Xie
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 20, 2025
Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With T2DM: A Multicenter Real-World Study.Zeyu Xie, Bin Gan, Weiling Cao
|Nov 03, 2025
Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis.Zeyu Xie, Weishang Deng, Zhuoru Liang
|Aug 18, 2025
Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review.Zeyu Xie, Zhuoru Liang, Yilin Xie
|Apr 29, 2024
Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.Zeyu Xie, Jia Hu, Mengting Li
|Dec 13, 2022
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review.Zeyu Xie, Sensen Yang, Weishang Deng
|Sep 06, 2022
A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease.Zeyu Xie, Jinjian Li, Sensen Yang
Pageof 1
